Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.

Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.

Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):934-41. doi: 10.1002/pds.1992.

PMID:
20623519
2.

Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?

Niederhofer H.

Psychiatr Danub. 2009 Sep;21(3):330. No abstract available.

3.

Improving decision making in the treatment of ADHD.

Vitiello B.

Am J Psychiatry. 2008 Jun;165(6):666-7. doi: 10.1176/appi.ajp.2008.08030365. No abstract available.

PMID:
18519529
4.

Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.

Arcieri R, Germinario EA, Bonati M, Masi G, Zuddas A, Vella S, Chiarotti F, Panei P; Italian Attention-Deficit/Hyperactivity Disorder Regional Reference Centers.

J Child Adolesc Psychopharmacol. 2012 Dec;22(6):423-431.

PMID:
23362511
5.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
6.

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.

Harpin VA.

Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864. Review.

PMID:
18356307
7.

Treatment of adult ADHD and comorbid disorders.

Young JL.

CNS Spectr. 2006 Oct;11(10 Suppl 11):10-2. No abstract available.

PMID:
17712918
8.

Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.

Eiland LS, Bell EA, Erramouspe J.

Ann Pharmacother. 2014 Oct;48(10):1350-5. doi: 10.1177/1060028014541791. Epub 2014 Jun 30. Review.

PMID:
24982313
9.

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR.

Aust N Z J Psychiatry. 2007 Mar;41(3):222-30.

PMID:
17464703
10.

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.

Kaplan G, Newcorn JH.

Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi. doi: 10.1016/j.pcl.2010.10.009. Review.

PMID:
21281851
11.

Effects of atomoxetine and methylphenidate on sleep in children with ADHD.

Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D.

Sleep. 2006 Dec;29(12):1573-85.

PMID:
17252888
12.

Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

Stiefel G, Besag FM.

Drug Saf. 2010 Oct 1;33(10):821-42. doi: 10.2165/11536380-000000000-00000. Review.

PMID:
20812768
13.
14.

Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.

[No authors listed]

Prescrire Int. 2010 Feb;19(105):5-8.

PMID:
20455329
15.

Attention deficit hyperactivity disorder: part III.

Ryan-Krause P.

J Pediatr Health Care. 2011 Jan-Feb;25(1):50-6. doi: 10.1016/j.pedhc.2010.10.001. No abstract available.

PMID:
21147408
16.

Pharmacotherapy of ADHD in adults.

Wilens TE.

CNS Spectr. 2008 May;13(5 Suppl 8):11-3. No abstract available.

PMID:
18567133
17.

Pharmacological management of attention-deficit hyperactivity disorder.

Reeves G, Schweitzer J.

Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. Review.

PMID:
15163276
18.

Attention deficit hyperactivity disorder in adults.

Rösler M, Casas M, Konofal E, Buitelaar J.

World J Biol Psychiatry. 2010 Aug;11(5):684-98. doi: 10.3109/15622975.2010.483249. Review.

PMID:
20521876
19.

Medications for adolescents with attention-deficit/hyperactivity disorder.

Soileau EJ Jr.

Adolesc Med State Art Rev. 2008 Aug;19(2):254-67, viii-ix. Review.

PMID:
18822831
20.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419

Supplemental Content

Support Center